Susquehanna International Group’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23K | Buy |
+2,070
| New | +$18.5K | ﹤0.01% | 12833 |
|
|
2025
Q2 | – | Sell |
-3,390
| Closed | -$37K | – | 13162 |
|
|
2025
Q1 | $37K | Sell |
3,390
-14,070
| -81% | -$152K | ﹤0.01% | 11957 |
|
|
2024
Q4 | $175K | Sell |
17,460
-3,180
| -15% | -$40.1K | ﹤0.01% | 10872 |
|
|
2024
Q3 | $341K | Buy |
20,640
+2,070
| +11% | +$29.5K | ﹤0.01% | 9324 |
|
|
2024
Q2 | $206K | Buy |
18,570
+4,970
| +37% | +$61.7K | ﹤0.01% | 10294 |
|
|
2024
Q1 | $180K | Buy |
13,600
+2,350
| +21% | +$30.5K | ﹤0.01% | 10717 |
|
|
2023
Q4 | $169K | Buy |
11,250
+1,300
| +13% | +$15.9K | ﹤0.01% | 10856 |
|
|
2023
Q3 | $146K | Buy |
9,950
+1,440
| +17% | +$27.7K | ﹤0.01% | 10564 |
|
|
2023
Q2 | $214K | Sell |
8,510
-7,390
| -46% | -$124K | ﹤0.01% | 10146 |
|
|
2023
Q1 | $237K | Sell |
15,900
-1,610
| -9% | -$29.9K | ﹤0.01% | 10229 |
|
|
2022
Q4 | $245K | Buy |
17,510
+16,380
| +1,450% | +$447K | ﹤0.01% | 9612 |
|
|
2022
Q3 | $36K | Sell |
1,130
-880
| -44% | -$36.8K | ﹤0.01% | 12382 |
|
|
2022
Q2 | $70K | Sell |
2,010
-2,410
| -55% | -$154K | ﹤0.01% | 11769 |
|
|
2022
Q1 | $499K | Buy |
+4,420
| New | +$512K | ﹤0.01% | 8978 |
|
|
2021
Q3 | – | Sell |
-3,190
| Closed | -$391K | – | 13125 |
|
|
2021
Q2 | $391K | Sell |
3,190
-1,530
| -32% | -$212K | ﹤0.01% | 10191 |
|
|
2021
Q1 | $752K | Buy |
4,720
+2,940
| +165% | +$499K | ﹤0.01% | 8461 |
|
|
2020
Q4 | $272K | Sell |
1,780
-430
| -19% | -$77.2K | ﹤0.01% | 9462 |
|
|
2020
Q3 | $410K | Buy |
+2,210
| New | +$362K | ﹤0.01% | 8089 |
|
|
2018
Q4 | – | Sell |
-397
| Closed | -$44K | – | 9403 |
|
|
2018
Q3 | $44K | Buy |
397
+324
| +444% | +$846K | ﹤0.01% | 8878 |
|
|
2018
Q2 | $199K | Sell |
73
-58
| -44% | -$134K | ﹤0.01% | 8615 |
|
|
2018
Q1 | $357K | Sell |
131
-37
| -22% | -$84.9K | ﹤0.01% | 7322 |
|
|
2017
Q4 | $400K | Buy |
168
+135
| +409% | +$298K | ﹤0.01% | 7055 |
|
|
2017
Q3 | $66K | Buy |
+33
| New | +$43.1K | ﹤0.01% | 8476 |
|
|
2017
Q1 | – | Sell |
-38
| Closed | -$66K | – | 9415 |
|
|
2016
Q4 | $66K | Hold |
38
| – | – | ﹤0.01% | 9217 |
|
|
2016
Q3 | $92K | Buy |
38
+3
| +9% | +$7.4K | ﹤0.01% | 7971 |
|
|
2016
Q2 | $87K | Sell |
35
-36
| -51% | -$118K | ﹤0.01% | 8084 |
|
|
2016
Q1 | $256K | Sell |
71
-401
| -85% | -$1.39M | ﹤0.01% | 7524 |
|
|
2015
Q4 | $2.17M | Buy |
472
+149
| +46% | +$486K | ﹤0.01% | 3864 |
|
|
2015
Q3 | $521K | Buy |
323
+291
| +909% | +$1.46M | ﹤0.01% | 7033 |
|
|
2015
Q2 | $266K | Buy |
+32
| New | +$305K | ﹤0.01% | 8758 |
|
Other funds holding IMUX
APM
BI
VCM
SCM
LCM
NCM
6CM
Susquehanna International Group's IMUX Position: Q1 2026 in Review
Susquehanna International Group increased its Immunic (IMUX) stake by 208% in Q1 2026, buying an estimated $622K and bringing the position to 102,826 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #7538.
Susquehanna International Group first reported a position in IMUX in Q2 2014 and has held it in 27 quarters since. The position peaked at $1.32M in Q1 2018. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.
- Susquehanna International Group held 102,826 shares of Immunic worth $1.14M as of Q1 2026.
- Susquehanna International Group bought 69,443 Immunic shares in Q1 2026, an estimated $622K.
- Immunic made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7538 holding.
- Susquehanna International Group first reported a position in Immunic in Q2 2014 and has held it in 27 quarters since.
- Susquehanna International Group's Immunic position peaked at $1.32M in Q1 2018.
- 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.